Breaking News

SimplyRFiD Brings RAIN RFID ROI to the NRF Big Show

SimplyRFiD spent a year gathering data on the ROI for RFID in retail and has the numbers and process improvements that show retailers implementing Wave RFID gain a minimum of 9.7% revenue improvement. SimplyRFID will be in booth #4246 at the NRF Big Show to discuss how Wave RFID can improve retailers’ top and bottom line.

SimplyRFiD Brings RAIN RFID ROI to the NRF Big Show
Wave RFID for inventory in retail

Wave RFID produces ROI in retail stores

DALLAS – January 5, 2023 – (Newswire.com)

Before RFID, the only choice was manual barcode counts that took hours or days and were only 75-85% accurate. Still, when RFID became viable around 2008, the value of RFID wasn’t there because the concept of a global accurate, available inventory didn’t exist. As omnichannel and e-commerce became a driving requirement for retailers, connecting inventory at the store to the web changed the value proposition for RFID.

Quarterly inventories are now obsolete. Today’s inventories are weekly – even daily – and take minutes with SimplyRFiD’s Wave RAIN RFID system.

After a year of study at retailers, SimplyRFiD found several areas that make the value proposition even more compelling. SimplyRFiD developed the business processes and workflows to help retailers get up and running with minimal effort and with high confidence of a successful, fast rollout.

Key ROI findings when implementing the SimplyRFiD Wave RFID System for inventory:

  • Increased Sales: 4% increase in sales due to product availability or replacement from nearby locations.
  • Labor Reduction: 95% less labor required for RFID inventory over manual.
  • Loss Reduction: Switching to fast, accurate weekly inventories reduced loss by 90% due to immediate identification and correction of diversion / leakage / misshipments.

SimplyRFiD will be at the NRF Big Show in booth #4246 from Jan. 15-17, 2023. On hand to discuss how SimplyRFiD can help retailers improve their business with RFID will be Carl Brown, President, Eric Richmond, Vice President of Delivery; and Will Montalbo, Vice President of Marketing.

Not sure if you need RFID for your inventory?

Wave RFID works for retailers from one store to 1,000. Even without omnichannel selling, the ability to locate items with RFID and get control of store inventory is a boon for small retailers and has the majority of the value. Complete single-store Wave RFID inventory systems well-equipped are less than $3,000 with hardware, software and support. Per tag RFID costs run $0.10-0.15 in small volumes and less than $0.04 in mid-volume.

Please contact SimplyRFID at [email protected] to reserve a time slot for a demo and analysis.

Contact Information:

William Montalbo

Vice President, Marketing
[email protected]

+1 703.343.1689

Press Release Service
by
Newswire.com

Original Source:

SimplyRFiD Brings RAIN RFID ROI to the NRF Big Show

AQuity and Savista Announce Strategic Partnership for Savista Transcription & Clinical Documentation Clients

Current Savista clients will migrate to AQuity’s industry-leading solutions in 2023 in a planned migration

ALPHARETTA, Ga. – January 5, 2023 – (Newswire.com)

AQuity Solutions and Savista today announced a strategic partnership and jointly-planned migration of current Savista transcription clients in 2023 to AQuity’s market-leading clinical documentation capture solutions. AQuity has been consistently recognized by KLAS and Black Book as the benchmark in the clinical documentation solutions sector, with over 45 years of experience in healthcare. Traditional transcription remains a critical part of middle-revenue cycle. The accurate capture of the clinical encounter, patient treatment, and severity of illness is key for proper care and appropriate reimbursement. 

“We are delighted to welcome legacy Savista transcription and clinical documentation clients to AQuity through this strategic partnership with Savista,” added Kashyap Joshi, CEO of AQuity. “Traditional transcription workflows continue to be a vital part of healthcare revenue cycle and we continue to see transcription as an important option for our healthcare providers to properly capture the patient story and deliver care to patients.”

“The AQuity transcription platform adds significant value to our Transcription service clients,” added Laxmi Patel, Chief Strategy Officer of Savista. “The platform’s unique security and reporting features, complemented by the strength of their ongoing product development, are true competitive advantages in this still important segment of our industry. This technology partnership supports our commitment to serve our clients with the best tools available.”

About Savista

Savista is a prominent provider of healthcare revenue cycle management services, partnering with hospitals, systems, physician practices and ambulatory surgery centers for over 30 years. They solve revenue cycle challenges through their comprehensive audits and assessments and expert staffing solutions that span eligibility and enrollment, CDM, coding, AR and more. Their global organization delivers custom solutions to over 300 clients across 770 facilities in 49 states. To learn more about Savista, please visit SavistaRCM.com.

About AQuity

Headquartered in Cary, NC, AQuity employs over 7,500 clinical documentation and medical coding professionals across the United States, India, Australia, Canada, and the U.K. With over 45 years of experience in service and technology solutions, AQuity is recognized year after year by KLAS and Black Book as a leading vendor in multiple disciplines with over 20 recognitions. AQuity is privately held.

https://aquitysolutions.com/

PRESS CONTACTS

Kim Wiethorn                                                

VP, Marketing and Communications              

[email protected]                      

513-884-7597                                                     

Contact Information:

Dale Kivi

Senior Director of Communications
[email protected]

804.339.9017

Press Release Service
by
Newswire.com

Original Source:

AQuity and Savista Announce Strategic Partnership for Savista Transcription & Clinical Documentation Clients

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society

The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society
ZetrOZ presents at the MLB winter meetings to PBATS

ZetrOZ presents at the MLB winter meetings to PBATS

SAN DIEGO – January 5, 2023 – (Newswire.com)

ZetrOZ Systems hosted a Lunch and Lecture for The Professional Baseball Athletic Trainers Society (PBATS) during the Major League Baseball Winter Meetings at the Manchester Grand Hyatt in San Diego, California. Founder and CEO Dr. George Lewis presented scientific updates on sustained acoustic medicine (sam®) research in sports medicine, reviewed a 2022 Healthcare Provider Survey on utilization within professional athletics and results from real-world clinicals, and introduced its Player Performance Packages for 2023.

“It was a pleasure to have the opportunity to speak with The Professional Baseball Athletic Trainers Society,” said Dr. Lewis. “I am grateful for the opportunity to share my knowledge and recent findings with such a professional and dedicated group of trainers. I look forward to continuing the conversation and working together to improve the health, performance and recovery of athletes in the future.”

Some of the key findings from the latest sports medicine research include the following:

  • Professional sports medical staff had an 87% satisfaction rate pDraper et al. 2021 J. Ortho. Practice).
  • When patients failed to respond to physical therapy, sam® proved to be a helpful adjunct to facilitate healing and return to work (Winkler et al. 2021 Nature Sports Med).
  • Athletic Trainers working within the professional, collegiate and military levels found sam® provided clinical patient improvement in under two weeks of treatment and a 50% reduction of pain medication pWalters et al. 2022 Open Orthopedics).
  • 87.3% of athletes are highly receptive to treatment, have a high confidence level for improved function, and return to work after 30 days of sam® use pOpen Orthopedics).

Over 30 studies back sustained acoustic medicine’s effectiveness, and over 1 million individuals have used sam® to treat soft tissue injuries. Today, 99% of Major League Baseball (MLB) organizations utilize sam® to treat injuries and accelerate soft tissue healing.

Dr. Lewis also introduced the company’s 2023 Player Performance Packages, designed for prophylactic injury prevention and soft tissue healing. A package includes one sam®x1 unit, a 10-week supply of patches, and 100% damage coverage. ZetrOZ is preparing its deployment training over the next several weeks before MLB’s 2023 Spring Training, officially beginning on Friday, Feb. 24.

“Now every player from the big leagues to the minors has access to sam® treatment. We are looking to reduce common injuries to the shoulder and elbow,” he added.

sam® is the first and only FDA-cleared, non-surgical and drug-free wearable long-duration mechanobiological device for home use designed to treat chronic inflammatory diseases and accelerate soft tissue healing. To learn more, visit zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine and developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetrozsystems.com.

Contact Information:

Buse Kayar
[email protected]

Press Release Service
by
Newswire.com

Original Source:

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society